Synopsys Shares Slide on Weak Guidance Despite Earnings Beat

BenzingaBenzinga
|||1 min read
Key Takeaway

Synopsys beat Q1 earnings but stock fell 3.44% on weak forward guidance, flat IP revenue, and China weakness concerns.

Synopsys Shares Slide on Weak Guidance Despite Earnings Beat

Synopsys Inc. shares declined 3.44% on Thursday following the semiconductor design software company's first-quarter earnings announcement, which exceeded profit expectations but fell short on forward guidance. The company reported adjusted earnings per share of $3.77 and revenue of $2.41 billion, surpassing analyst estimates. However, the positive earnings surprise was overshadowed by cautious second-quarter projections and concerning trends in key business segments.

The company's intellectual property revenue remained flat sequentially in the quarter, while second-quarter sales guidance came in below consensus expectations. These metrics prompted concern among investors about the sustainability of growth momentum, particularly as the company navigates macroeconomic headwinds. The guidance shortfall signals potential softness in near-term demand for Synopsys's core offerings.

Analyst Clarke Jeffries responded to the results by lowering the price target from $520 to $430 per share, citing underwhelming performance metrics and weakness in China revenue attributed to ongoing technology restrictions and geopolitical constraints. The analyst action reflects broader concerns about the company's exposure to international markets and the impact of trade limitations on its business outlook. The combination of tepid guidance and regional revenue challenges appears to have offset the company's ability to meet quarterly earnings targets.

Source: Benzinga

Back to newsPublished Feb 26

Related Coverage

The Motley Fool

Rackspace Soars 56% on AMD AI Infrastructure Deal, Returns to Profit

Rackspace surges 56% after announcing AMD AI infrastructure partnership and posting Q1 profitability return with 2% revenue growth to $678 million.

AMDRXTAKAM
The Motley Fool

Palantir Crushes Q1 Earnings as Stock Pullback Triggers Valuation Debate

Palantir crushed Q1 2026 earnings but stock pullback from recent highs triggers investor debate over valuation and entry points.

PLTR
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

ImmunityBio Stock Plummets 21% After FDA Warning Over Anktiva Cancer Claims

ImmunityBio faces securities fraud lawsuit after FDA warning letter alleges false Anktiva promotional claims. Stock dropped 21% to $7.42.

IBRX
Benzinga

Johnson Outdoors Beats Earnings But Cost Pressures Weigh on Stock

Johnson Outdoors delivered strong Q2 results with 16% sales growth and margin expansion, but flagged mounting cost pressures and inventory challenges, causing shares to decline.

JOUT
The Motley Fool

MercadoLibre Stock Plunges 11% Despite Revenue Beat and Strong Cash Flow

MercadoLibre shares fell 11% after Q1 earnings beat revenue expectations but missed profit forecasts, as the company invests heavily in growth. Free cash flow doubled to $1.8B, trading at attractive 7.1x FCF multiple.

MELI